Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / TEVA - Are Chloroquine and Hydrochloroquine Approved to Treat COVID-19?


TEVA - Are Chloroquine and Hydrochloroquine Approved to Treat COVID-19?

Despite what President Donald Trump said at a White House briefing on Thursday, the Food and Drug Administration (FDA) hasn't approved chloroquine and its less-potent-but-safer offspring, hydrochloroquine, to treat COVID-19, the disease caused by the new coronavirus.

"Normally the FDA would take a long time to approve something like that, and it's -- it was approved very, very quickly and it's now approved, by prescription," Trump said.

Neither chloroquine nor hydrochloroquine are approved by the FDA to treat COVID-19, but they are approved to treat malaria -- and have been for decades. Hydrochloroquine is also used to treat lupus and rheumatoid arthritis since it has anti-inflammatory properties.

Continue reading

Stock Information

Company Name: Teva Pharmaceutical Industries Limited American Depositary Shares
Stock Symbol: TEVA
Market: NYSE
Website: tevapharm.com

Menu

TEVA TEVA Quote TEVA Short TEVA News TEVA Articles TEVA Message Board
Get TEVA Alerts

News, Short Squeeze, Breakout and More Instantly...